Sanjay Popat, Thoracic Oncologist at The Royal Marsden NHS Foundation Trust, shared on X:
“Stephanie Saw discusses Asian subset data from osimertinib reminding us that osi has not performed as well in Asian subsets as non-Asian subsets, highlighting that perhaps germline EGFR intron 1 polymorphism may contribute to sensitivity.”
